Security key
74168J101
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 181,672,212
- Total 13F shares
- 68,888,470
- Share change
- +2,179,395
- Total reported value
- $353,995,003
- Put/Call ratio
- 40%
- Price per share
- $5.14
- Number of holders
- 119
- Value change
- +$8,574,594
- Number of buys
- 68
- Number of sells
- 50
Report period
Q2 2024
Institutions
119
Top holders
10
PRME full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Prime Medicine, Inc. SEC filings
Prime Medicine, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74168J101
Recent filing periods:
Top shareholders of PRME - Prime Medicine, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Alphabet Inc. |
13F
|
Company |
8.3%
|
15,062,498
|
$105,437,486 | — | 31 Mar 2024 | |
| ARK Investment Management LLC |
13F
|
Company |
3.3%
|
5,993,354
|
$41,953,475 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
5,801,445
|
$40,610,115 | — | 31 Mar 2024 | |
| FMR LLC |
3/4/5
13F
|
Other* · Company |
2.2%
from 13F
|
8,462,946
|
$126,699,612 | — | 24 Oct 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.1%
|
3,756,210
|
$26,293,470 | — | 31 Mar 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.9%
|
3,364,663
|
$23,552,641 | — | 31 Mar 2024 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1.9%
|
3,364,663
|
$23,518,994 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.7%
|
3,090,083
|
$21,631,000 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.4%
|
2,522,590
|
$17,660,000 | — | 31 Mar 2024 | |
| Redmile Group, LLC |
13F
|
Company |
1.1%
|
2,074,350
|
$14,520,450 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
1.1%
|
1,990,000
|
$13,930,000 | — | 31 Mar 2024 | |
| MWG Management Ltd. |
13F
|
Company |
0.99%
|
1,792,210
|
$12,545,470 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.57%
|
1,028,466
|
$7,199,262 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
916,861
|
$6,418,684 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.49%
|
885,314
|
$6,197,198 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.43%
|
778,782
|
$5,451,474 | — | 31 Mar 2024 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.41%
|
750,000
|
$5,250,000 | — | 31 Mar 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.39%
|
700,000
|
$4,900,000 | — | 31 Mar 2024 | |
| Greenwich Wealth Management LLC |
13F
|
Company |
0.32%
|
578,001
|
$4,046,000 | — | 31 Mar 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.3%
|
540,304
|
$3,782,128 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.28%
|
508,078
|
$3,556,546 | — | 31 Mar 2024 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.28%
|
500,000
|
$3,500,000 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.24%
|
435,317
|
$3,047,219 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.23%
|
421,420
|
$2,949,940 | — | 31 Mar 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
0.2%
|
367,175
|
$2,570,225 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.2%
|
362,400
|
$2,537,000 | — | 31 Mar 2024 | |
| Bollard Group LLC |
13F
|
Company |
0.2%
|
361,136
|
$2,528,000 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.2%
|
360,000
|
$2,520,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
339,998
|
$2,379,986 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.18%
|
330,500
|
$2,313,500 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
0.17%
|
303,716
|
$2,126,012 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
297,823
|
$2,084,761 | — | 31 Mar 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.11%
|
205,242
|
$1,436,694 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
198,466
|
$1,389,267 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
164,000
|
$1,148,000 | — | 31 Mar 2024 | |
| WESTWOOD HOLDINGS GROUP INC |
13F
|
Company |
0.09%
|
159,351
|
$1,115,000 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.08%
|
150,373
|
$1,052,611 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.08%
|
150,000
|
$1,050,000 | — | 31 Mar 2024 | |
| Vestmark Advisory Solutions, Inc. |
13F
|
Company |
0.08%
|
147,484
|
$1,032,388 | — | 31 Mar 2024 | |
| FIL Ltd |
13F
|
Company |
0.08%
|
138,276
|
$967,932 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.07%
|
129,022
|
$903,154 | — | 31 Mar 2024 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.06%
|
116,887
|
$818,209 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
108,198
|
$757,386 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
105,963
|
$741,741 | — | 31 Mar 2024 | |
| TrueMark Investments, LLC |
13F
|
Company |
0.05%
|
85,183
|
$596,281 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.04%
|
74,928
|
$524,496 | — | 31 Mar 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.03%
|
61,295
|
$429,065 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
59,566
|
$416,962 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
52,512
|
$367,584 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.03%
|
46,637
|
$327,392 | — | 31 Mar 2024 |
Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME) as of Q2 2024
As of 30 Jun 2024,
Prime Medicine, Inc. - COMMON STOCK (PRME) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,888,470 shares.
The largest 10 holders included
Alphabet Inc., ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, T. Rowe Price Investment Management, Inc., Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., Redmile Group, LLC, and MWG Management Ltd..
This page lists
119
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
112
Q2 2024 holders
119
Holder diff
7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.